☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Co-Promotion
Eagle Signs a Co-Promotion Agreement with Tyme for SM-88 to Treat Cancer
January 8, 2020
Gilead Signs a Co-Promotion Agreement with Eisai for Filgotinib in Japan
December 26, 2019
Sumitomo Dainippon Pharma Signs a Co-Promotion & Commercialization Agreement with Novartis for Diabetes in Japan
May 31, 2019
Load more...
Back to Home
Modal title
×
Modal body text goes here.